Recent Research Analysts’ Ratings Changes for Aveanna Healthcare (AVAH)

Aveanna Healthcare (NASDAQ: AVAH) recently received a number of ratings updates from brokerages and research firms:

• 8/19/2025 – Aveanna Healthcare was upgraded by analysts at Barclays PLC from an “equal weight” rating to an “overweight” rating. They now have a $9.50 price target on the stock, up previously from $5.50.
• 8/19/2025 – Aveanna Healthcare was upgraded by analysts at UBS Group AG from a “sell” rating to a “neutral” rating. They now have a $8.00 price target on the stock, up previously from $6.75.
• 8/12/2025 – Aveanna Healthcare had its price target raised by analysts at UBS Group AG from $5.00 to $6.75. They now have a “sell” rating on the stock.
• 8/11/2025 – Aveanna Healthcare was upgraded by analysts at Raymond James Financial, Inc. from a “market perform” rating to an “outperform” rating. They now have a $9.00 price target on the stock.
• 8/9/2025 – Aveanna Healthcare was upgraded by analysts at Wall Street Zen from a “buy” rating to a “strong-buy” rating.
• 7/21/2025 – Aveanna Healthcare was upgraded by analysts at Jefferies Financial Group Inc. from a “hold” rating to a “buy” rating. They now have a $6.00 price target on the stock, down previously from $6.25.
• 7/16/2025 – Aveanna Healthcare had its price target lowered by analysts at Truist Financial Corporation from $6.00 to $5.00. They now have a “hold” rating on the stock.

Insider Activity

In related news, major shareholder Paul R. Vigano sold 750,000 shares of the firm’s stock in a transaction that occurred on Tuesday, June 10th. The shares were sold at an average price of $5.20, for a total value of $3,900,000.00. Following the sale, the insider owned 28,890,756 shares in the company, valued at approximately $150,231,931.20. This trade represents a 2.53% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, CAO Deborah Stewart sold 15,457 shares of the firm’s stock in a transaction that occurred on Tuesday, June 10th. The stock was sold at an average price of $5.56, for a total transaction of $85,940.92. Following the completion of the sale, the chief accounting officer owned 285,396 shares in the company, valued at $1,586,801.76. This represents a 5.14% decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 2,295,145 shares of company stock valued at $11,941,141. Company insiders own 7.00% of the company’s stock.

Aveanna Healthcare Holdings Inc, a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities.